Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman's disease.

Kazutoshi Ebisawa,Arika Shimura,Akira Honda,Yosuke Masamoto,Fumio Nakahara,Mineo Kurokawa

Hemoglobin and C-reactive protein levels as predictive factors for long-term successful glucocorticoid treatment for multicentric Castleman's disease.

2020

Kazutoshi Ebisawa
Arika Shimura
Akira Honda
Yosuke Masamoto
Fumio Nakahara
Mineo Kurokawa

Although anti-interleukin-6 therapy with tocilizumab and siltuximab is recommended for multicentric Castleman’s disease (MCD), burdens caused by frequent hospital visits and high drug payments is a...

Keywords:

Gastroenterology
C-reactive protein
Medicine
Internal medicine
Prednisolone
Disease
Glucocorticoid
Hemoglobin
Drug
Tocilizumab
Siltuximab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations